Elanco opens autogenous poultry vaccine manufacturing facility

New state-of-the-art facility dedicated solely to manufacturing customized, high-quality, inactivated vaccines for poultry industry.

Elanco Animal Health officially opened the doors May 3 to its new autogenous poultry vaccine facility in Winslow, Maine.

The first of its kind for Elanco, the new state-of-the-art facility is dedicated solely to manufacturing customized, high-quality, inactivated vaccines for the poultry industry that will assist in preventing unique disease challenges and protecting from food safety issues that can’t be addressed with commercially available vaccines.

Milson Gondim, vice

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.


Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)


Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.


SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx


TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx


TAGS: Poultry
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish